Home › Funds › Sageworth Trust Co › ABT

Sageworth Trust Co position in ABT

ABBOTT LABORATORIES · Health Care

Sageworth Trust Co reported holding 17,975 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.08% of its reported portfolio and ranking #43 among its reported holdings. Sageworth Trust Co has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)17.98K sh
Reported value held$1.78M
Portfolio Weight0.08%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sageworth Trust Co's ABT position evolved

Sageworth Trust Co first disclosed a stake in ABT in Q3 2023 at 66,276 shares (US$6.4M). The position peaked in Q3 2025 at 56,711 shares, worth US$7.6M. Across 13 filings, Sageworth Trust Co increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 17,975 shares valued at US$1.8M. Notable position changes include a 57% increase in Q3 2025 (shares fell 6% over the following quarter), a 64% trim in Q4 2025 (shares fell 18% over the following quarter), a 37% increase in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 66.28K $6.42M New
Q4 2023 66.28K $7.29M Hold
Q1 2024 65.68K $7.46M Reduce
Q2 2024 63.27K $6.57M Reduce
Q3 2024 51.85K $5.91M Reduce
Q4 2024 35.99K $4.07M Reduce
Q1 2025 36.08K $4.79M Hold
Q2 2025 36.07K $4.91M Hold
Q3 2025 56.71K $7.60M Add
Q4 2025 20.36K $2.55M Reduce
Q1 2026 27.83K $2.86M Add
Q2 2026 17.93K $1.63M Reduce
Q3 2026 17.98K $1.78M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Sageworth Trust Co held ABT?

Sageworth Trust Co has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sageworth Trust Co's current position in ABT?

As of Q3 2026, Sageworth Trust Co holds 17.98K shares of ABT (ABBOTT LABORATORIES), valued at $1.78M, representing 0.08% of its reported portfolio and ranking #43.

Has Sageworth Trust Co been buying or selling ABT?

In the latest 13F filing (Q3 2026), Sageworth Trust Co held unchanged its position in ABT. The position peaked in Q3 2025 at 56.71K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.